Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations
Get Alerts TMO Hot Sheet
EPS Growth %: +6.7%
Financial Fact:
Total revenues: 4.49B
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) shares rose 3.55% after the company reported first-quarter earnings and revenue that exceeded Wall Street's expectations. The company's adjusted earnings per share (EPS) came in at $5.11, surpassing the analyst estimate of $4.71. Revenue for the quarter also beat consensus estimates, reaching $10.34 billion against expectations of $10.16 billion.
The science-serving leader saw a slight decline in revenue compared to the same quarter last year, with a 3% drop from $10.71 billion in 2023. Despite the decrease in revenue, Thermo Fisher's adjusted EPS saw a 2% increase from the $5.03 reported in the first quarter of the previous year. The company's GAAP diluted EPS grew by 4% to $3.46, up from $3.32 in the first quarter of 2023.
Marc N. Casper, chairman, president, and CEO, expressed satisfaction with the company's strong financial results, attributing the successful quarter to Thermo Fisher's growth strategy and the PPI Business System. Casper highlighted the company's commitment to customer success, strong commercial execution, and operational discipline as key factors positioning Thermo Fisher for differentiated performance in 2024.
Looking ahead, Thermo Fisher has raised its full-year guidance for 2024, now expecting revenue to be between $42.3 billion and $43.3 billion and adjusted EPS to range from $21.14 to $22.02. The midpoint of the adjusted EPS guidance range, $21.58, is slightly above the analyst consensus of $21.53. The midpoint of the revenue guidance, $42.8 billion, is below the consensus estimate of $42.83 billion.
The company's proactive capital deployment was also notable in the first quarter, with a $3.0 billion stock repurchase and an 11% dividend increase. These actions reflect Thermo Fisher's confidence in its financial strength and commitment to delivering shareholder value.
Thermo Fisher's first-quarter performance, characterized by a robust earnings and revenue beat, has set a positive tone for the company's outlook in 2024.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- United Community Banks sells equipment finance unit for $1.9 billion
- MIND Technology (MIND) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share